ArticleACS omega2025
Curcumin-Loaded ZIF-8 Nanomaterials: Exploring Drug Loading Efficiency and Biomedical Performance.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Evaluation of anti-hyperglycemic, hepatic gene-modulatory and tissue-protective effects of curcumin, curcumin-loaded zeolitic imidazolate framework-8, and metformin in zebrafish (Danio rerio).Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2026Article
- MOF-Enabled Nanocellulose Composite Threads for Sustained Antibacterial Drug Delivery and Minimally Invasive Soft-Tissue Lifting.Polymers · 2026Article
- An intelligent delivery system for apricot preservation: pH-responsive hollow ZIF-8 loaded with lavender essential oil and its preservation efficacy.Food chemistry: X · 2026Article
- Article
- Article
- Smart Ultrasound-Responsive Nanoparticles for Drug Delivery.IEEE nanotechnology magazine · 2026Article
- In situ synthesized Van-ZIF-8 functionalized electrospun PCL membrane with pH-responsive dual functionality for oral guided bone regeneration.Journal of materials science. Materials in medicine · 2026Article
- Evaluating the biological characteristics of targeted ZIF-8-encapsulated individual and combined drug systems for enhancedRSC advances · 2026Article
- Encapsulation of Snail Slime in Metal-Organic Framework ZIF-8.Journal of functional biomaterials · 2025Article
- A curcumin-enabled ZIF8 nanosystem enables ovarian cancer treatment by inducing mitochondrial disruption.Discover nano · 2025Article
- Synthesis of silk fibroin and silver nanoparticles for enhanced functionality in cellulosic textiles.Scientific reports · 2025Article
- Sustainable fabrication of TIF@ZIF-8 nanocomposites: characterization, antioxidant potential, and bioactive applications.Discover nano · 2025Article
- Vitexin as a Potential Antidysmenorrheic Agent: Development of a ZIF-8-Based Immediate-Release System and Evaluation via In Vivo and In Silico Approaches.Biomedicines · 2025Article
- Bioinspired synthesis of ultra-small copper-aspartate BioMOF nanodots using sodium caseinate for targeted curcumin delivery.Scientific reports · 2025Article
- Modulating cell adhesion and infiltration in advanced scaffold designs based on PLLA fibers with rGO and MXene (TiMaterials today. Bio · 2025Article
- Fabrication of3 Biotech · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin (cur) possesses excellent therapeutic properties, including anti-inflammatory, antioxidant, and healing-promoting effects. However, its biomedical application is impeded by its rapid degradation, limited bioavailability, and poor aqueous solubility. Zeolitic imidazole framework (ZIF-8), with a high surface area and tunable pore size, is designed and used as a cur delivery carrier to overcome these limitations. The synthesis of cur-loaded ZIF-8 involves a solvothermal method, followed by encapsulation of cur within the porous structure of ZIF-8. The amount of cur was varied to synthesize a series of panel cur-loaded ZIF-8. 0.5 mg/mL cur@ZIF-8 that showed higher drug loading efficiency (85.91 ± 1.26%) and drug loading capability (12.93 ± 0.19%) without changes in shape, size, crystallinity, chemical composition, and thermal stability of original ZIF-8. 0.5 mg/mL cur@ZIF-8 exhibited excellent surface area (1591.02 m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.